Login
欢迎浏览恩派尔生物资料网
我要投稿 请登录 免费注册 安全退出

您现在的位置是: 首页 > 实验方法 > 细胞技术

细胞技术

Anti-HMdU Autoantibodies in Human Sera as a Biomarker of Cancer Risk

2025-03-14 细胞技术 加入收藏
Our laboratory has discovered that blood sera of healthy men and women contain l

Our laboratory has discovered that blood sera of healthy men and women contain low levels of anti-HMdU (Shydroxymethyl-2′-deoxyuridine, an oxidized thymidine) autoantibodies (aAbs) (1 ,2 ) However, patients with chronic inflammatory diseases exhibit elevated anti-HMdU aAb titers. Interestingly, people at high risk for cancer, those with cancer and, most importantly, those who were diagnosed with breast, colon, and rectal cancer 0.5–6 yr after donation of the blood samples we analyzed (but not those diagnosed with nonmelanoma skin cancer) had significantly elevated anti-HMdU aAb titers (4 ). The high aAbs in apparently healthy women at the time of blood donation persisted for several years before diagnosis (3 ). We recently also showed that these anti-HMdU aAb titers depend on subject’s age and menopausal status (5 ) Our findings pomt to anti-HMdU aAb titers as being a biomarker of a potential to develop cancer even in the absence of family risk factors, which constitute the majority of cases

文章底部广告位

文章评论

加载中~